Skip to content

Drug interactions

Lapatinib + Methylprednisolone

Severity: Moderate

Lapatinib and Methylprednisolone: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lapatinib inhibits CYP3A4 and P-glycoprotein and may increase methylprednisolone exposure. This can intensify corticosteroid adverse effects such as hyperglycemia, fluid retention and immunosuppression.

What this interaction means in plain words

Lapatinib and Methylprednisolone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lapatinib belongs to Oncology; Methylprednisolone belongs to Endocrine.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 metabolism and P-glycoprotein efflux by lapatinib raises methylprednisolone concentrations.

What to do

Monitor for signs of corticosteroid excess, and reduce the methylprednisolone dose if they develop. Check blood glucose in susceptible patients.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lapatinib and Methylprednisolone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lapatinib with Methylprednisolone?

MediHelp rates the interaction as moderate. Lapatinib and Methylprednisolone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lapatinib inhibits CYP3A4 and P-glycoprotein and may increase methylprednisolone exposure. This can intensify corticosteroid adverse effects such as hyperglycemia, fluid retention and immunosuppression.

How serious is the interaction between Lapatinib and Methylprednisolone?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for signs of corticosteroid excess, and reduce the methylprednisolone dose if they develop. Check blood glucose in susceptible patients.

What other medicines interact with Methylprednisolone?

MediHelp also lists interactions of Methylprednisolone with, for example, Bcg vaccine live, Measles mumps and rubella vaccine live, Measles mumps rubella and varicella vaccine live. The full list is on the Methylprednisolone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in